Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boulder/denver blog main
detroit blog main
indiana blog main
national
3
×
national blog main
national top stories
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
3
×
texas blog main
texas top stories
wisconsin blog main
arvinas
biotech
boston top stories
boulder/denver top stories
detroit top stories
indiana top stories
life sciences
medical devices
merck
new york top stories
president trump
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle top stories
startups
wisconsin top stories
abbvie
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
antibiotics
astrazeneca
What
company
3
×
acquisitions
albert
biggest
bio
biotechs
bourla
business
ceo
chose
close
comes
control
crispr
developing
device
drug
effect
execs
external
factors
firms
founders
future
immigration
imports
innovation
investors
ipo
ipos
leaders
life
make
maker
maps
measured
medical
open
patients
pfizer
Language
unknown
Current search:
national
×
company
×
" seattle blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way